01 · THE CUSTOMER PROBLEM
Orthopedic teams need an implant interface that adds biological function without creating an uncontrolled coating, release or degradation profile.
A specification-controlled chitosan system can combine surface functionalization, localized delivery and a temporary regenerative interface within one adaptable material family.
Chitosan offers a versatile interface between an orthopedic device and the biological environment around it.
02 · RECOMMENDED STARTING POINT
Start with the material designed for the decision.
From the implant surface to the surrounding scaffold, engineered chitosan can support coating, regeneration and localized-delivery concepts in one biodegradable material system.
Without the shell
Controlled fungal sourcing supports a traceable, non-animal supply strategy.
Specification engineered
MW, DDA, purity, charge density and format are selected around the target result.
Application ready
Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.
One technical partner
Material selection, formulation support and the validation plan are connected from the first sample.
03 · PERFORMANCE TARGETS
Build toward outcomes a buyer can measure.
Implant coatings
Thin chitosan layers can functionalize titanium, PEEK and composite surfaces or carry additional bioactive components.
Bone scaffolds
Porous matrices and composites provide an adaptable structure for bone-regeneration research and tissue integration.
Localized delivery
Coatings and hydrogels can be engineered to retain and release selected antimicrobials, proteins or small molecules near the implant.
Absorbable interfaces
ABC material design enables degradation profiles to be developed around healing timelines and final-device requirements.
04 · GO / NO-GO CRITERIA
Define the evidence before testing begins.
The first program is designed around three decision-making outputs—not an open-ended material trial.
Adhesion before and after sterilization
Endotoxin and cytocompatibility
Release and degradation profile
05 · FROM SAMPLE TO DECISION
A practical application program,
not a bag of powder.
Define
Agree on the function, baseline, constraints and measurable success criteria.
Screen
Select the MW, DDA, purity, dose and physical format that fit the application.
Validate
Test the winning system in the finished formulation, device, process or use environment.
Recommended first request: Coating-grade ChitoGene with EndoFree and ABC options, plus an implant-surface development brief.
Start the Sample Brief06 · WHY CHITOSAN
A functional tissue interface
Coatings, fibers, films, gels and porous matrices can create a modifiable interface on metals, polymers, composites or wound-contact structures.
There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.
Biocompatibility, endotoxin, sterilization, mechanics and degradation are qualified around the final device and contact classification.